我国替代蛋白行业发展调研分析及管理模式探讨
CSTR:
作者:
作者单位:

国家食品安全风险评估中心,北京 100022

作者简介:

欧曈 男 助理研究员 研究方向为新食品原料安全性评估 E-mail: outong@cfsa.net.cn

通讯作者:

宋雁 女 研究员 研究方向为食品安全风险评估 E-mail: songyan@cfsa.net.cn
李宁 女 研究员 研究方向为食品安全风险评估和食品毒理学 E-mail: lining@cfsa.net.cn

中图分类号:

R155

基金项目:

中国工程院战略研究与咨询项目(2022-XZ-57)


Exploration of development status and management models in China’s alternative protein industry
Author:
Affiliation:

China National Center for Food Safety Risk Assessment, Beijing 100022, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 为落实“大食物观”和健康中国发展战略,了解我国替代蛋白产品研发生产情况,初步提出相应的管理和政策建议。方法 通过行业调研分析替代蛋白产品类型,对比不同产品的生产工艺特征,形成我国各类替代蛋白管理政策的科学建议。结果 本次调研的40家企业中替代蛋白的产品包括细胞培育肉、微生物蛋白、藻类蛋白、昆虫蛋白和植物蛋白5种来源。不同类别产品的生产工艺差异较大,细胞培育肉的主要工艺为种子细胞选育、扩繁,微生物和藻类替代蛋白主要为发酵扩繁,昆虫和植物替代蛋白是以提取工艺为核心。其中,细胞培育肉更适合采用“个案分析”管理模式,微生物蛋白、藻类蛋白和昆虫蛋白的技术相对成熟,可以根据其食用和使用特点,参照新食品原料管理要求进行管理,而部分植物替代蛋白则可按照普通食品进行管理。结论 替代蛋白基本属于我国新食品原料管理范畴,但需分类制定申报材料要求及审评规则,以促进行业健康和高质量发展。

    Abstract:

    Objective This study aimed to investigate the status of research, development, and production of alternative protein products in China, in order to propose evidence-based regulatory and policy recommendations.Methods An industry survey was conducted to analyze the types of alternative protein products and compare their production processes. Based on this, science-based management policy suggestions for China were formulated.Results The alternative protein produced by 40 surveyed enterprises included cell-cultivated meat, microbial protein, algae protein, insect protein, and plant protein. Significant process variations were observed that cell-cultivated meat focused on cell selection and proliferation, microbial proteins and algae proteins emphasized fermentation, while insect proteins and plant proteins prioritized extraction technologies. Specifically, a case-by-case approval is recommended for cell-cultivated meat. In contrast, microbial, algal, and insect proteins, with their more established technologies, can be regulated under novel food requirements based on their intended uses. Certain plant-based alternative proteins can be regulated as conventional foods.Conclusion While alternative proteins are managed as novel food under Chinese regulatory frameworks, the development of category-specific application guidelines and evaluation criteria is necessary to facilitate sustainable and high-standard industry growth.

    参考文献
    相似文献
    引证文献
引用本文

欧曈,雍凌,孙绍鑫,肖潇,宋雁,刘兆平,李宁.我国替代蛋白行业发展调研分析及管理模式探讨[J].中国食品卫生杂志,2026,38(2):150-156.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-01-07
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-06-01
  • 出版日期:
文章二维码
严正声明
关闭